ArticleClinical cancer research : an official journal of the American Association for Cancer Research2022

DOT1L Is a Novel Cancer Stem Cell Target for Triple-Negative Breast Cancer.

Hetakshi Kurani et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.